Stock A137310 SD BIOSENSOR, INC
Add to a list
To use this feature you must be a member
Log inSign up

Financials SD BioSensor, Inc

Equities

A137310

KR7137310009

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-14 pm EDT 		5-day change 1st Jan Change
9,210 KRW -0.75% Intraday chart for SD BioSensor, Inc -2.95% -19.49%
2023 SD Biosensor, Inc announced that it has received KRW 226.0893359 billion in funding from BioNote, Inc. CI
2023 SD Biosensor, Inc announced that it expects to receive KRW 226.0893359 billion in funding from BioNote, Inc. CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 5,736,545 3,074,925 1,399,655
Enterprise Value (EV) 1 4,036,714 1,035,648 1,450,414
P/E ratio 5.16 x 3.35 x -2.71 x
Yield 2.26% 3.28% -
Capitalization / Revenue 1.96 x 1.05 x 2.13 x
EV / Revenue 1.38 x 0.35 x 2.21 x
EV / EBITDA 2.92 x 0.87 x -13.1 x
EV / FCF 5,174,578 x 2,573,672 x -5,798,556 x
FCF Yield 0% 0% -0%
Price to Book 2.58 x 1.05 x 0.5 x
Nbr of stocks (in thousands) 102,622 101,988 122,347
Reference price 2 55,900 30,150 11,440
Announcement Date 3/21/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales 1 73,728 1,686,163 2,929,961 2,932,001 655,677
EBITDA 1 5,409 746,239 1,383,155 1,187,444 -110,543
EBIT 1 895.5 738,264 1,364,041 1,146,624 -248,085
Operating Margin 1.21% 43.78% 46.55% 39.11% -37.84%
Earnings before Tax (EBT) 1 563.1 717,237 1,440,817 1,242,088 -438,614
Net income 1 1,399 615,636 1,064,778 911,362 -467,712
Net margin 1.9% 36.51% 36.34% 31.08% -71.33%
EPS 2 135.0 6,583 10,824 8,997 -4,219
Free Cash Flow - 326,120 780,105 402,401 -250,134
FCF margin - 19.34% 26.63% 13.72% -38.15%
FCF Conversion (EBITDA) - 43.7% 56.4% 33.89% -
FCF Conversion (Net income) - 52.97% 73.26% 44.15% -
Dividend per Share - 535.0 1,266 990.0 -
Announcement Date 4/28/20 5/14/21 3/21/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 443.8 1,388 795 551.2 193.8 182.4 162.6 151 159.6
EBITDA 1 - - - - - - - -9.591 13.3
EBIT 1 147.9 619.6 348.1 293.4 -114.6 -123.8 -76.41 -44.24 -29.61
Operating Margin 33.32% 44.63% 43.79% 53.24% -59.13% -67.86% -46.98% -29.29% -18.55%
Earnings before Tax (EBT) 156 648.7 466.9 487.4 -361 - - - -
Net income 1 130.5 474.5 340 421.3 -352.4 - -82.49 -64.12 -98.43
Net margin 29.4% 34.17% 42.77% 76.44% -181.84% - -50.72% -42.45% -61.67%
EPS - - - - - - - - -
Dividend per Share - - - - - - - - -
Announcement Date 2/25/22 5/12/22 8/3/22 11/3/22 3/9/23 5/15/23 8/11/23 11/13/23 2/28/24
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 - - - - 50,759
Net Cash position 1 26,420 443,867 1,699,830 2,039,277 -
Leverage (Debt/EBITDA) - - - - -0.4592 x
Free Cash Flow - 326,120 780,105 402,401 -250,134
ROE (net income / shareholders' equity) - 139% 71.9% 35.1% -16.2%
ROA (Net income/ Total Assets) - 56.6% 38.2% 22.8% -4.4%
Assets 1 - 1,088,315 2,789,437 4,003,279 10,634,400
Book Value Per Share 2 12,693 8,016 21,658 28,794 23,079
Cash Flow per Share 2 3,842 2,606 8,716 18,317 3,943
Capex 1 6,079 54,904 190,053 301,999 142,566
Capex / Sales 8.25% 3.26% 6.49% 10.3% 21.74%
Announcement Date 4/28/20 5/14/21 3/21/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
SD BIOSENSOR, INC Stock SD BioSensor, Inc
-19.49% 815M
BIOMÉRIEUX Stock bioMérieux
-5.32% 12.28B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+98.69% 8.54B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-22.31% 6.58B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+6.46% 5.77B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-23.61% 3.48B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+5.84% 2.54B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+39.18% 2.41B
VITROLIFE AB Stock Vitrolife AB
-7.65% 2.3B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-69.05% 2.07B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. A137310 Stock
  4. Financials SD BioSensor, Inc